Adenosine deaminases acting on RNA (ADARs) are both antiviral and proviral - Test2 - elhamkhani - TriplyDB

Adenosine deaminases acting on RNA (ADARs) are both antiviral and proviral

Adenosine deaminases acting on RNA (ADARs) are both antiviral and proviral

http://www.wikidata.org/entity/Q28302608

about

Restricting retrotransposons: a review Translating the epitranscriptome ADAR1, inosine and the immune sensing system: distinguishing self from non-self To edit or not to edit: regulation of ADAR editing specificity and efficiency The Epitranscriptome and Innate Immunity New Insights into the Biological Role of Mammalian ADARs; the RNA Editing Proteins Adenosine-to-inosine RNA editing and human disease dsRNA-activation of TLR3 and RLR signaling: gene induction-dependent and independent effects Protein kinase PKR and RNA adenosine deaminase ADAR1: new roles for old players as modulators of the interferon response Rapid and dynamic transcriptome regulation by RNA editing and RNA modifications Insights into the antiviral immunity against grass carp (Ctenopharyngodon idella) reovirus (GCRV) in grass carp The interactomes of influenza virus NS1 and NS2 proteins identify new host factors and provide insights for ADAR1 playing a supportive role in virus replication Enhancement of replication of RNA viruses by ADAR1 via RNA editing and inhibition of RNA-activated protein kinase The origin of the ADAR gene family and animal RNA editing The dynamic epitranscriptome: A to I editing modulates genetic information Profiling RNA editing in human tissues: towards the inosinome Atlas Genomic analysis of ADAR1 binding and its involvement in multiple RNA processing pathways A quantitative proteomic analysis of lung epithelial (A549) cells infected with 2009 pandemic influenza A virus using stable isotope labelling with amino acids in cell culture.BMix: probabilistic modeling of occurring substitutions in PAR-CLIP data.Ribonuclease L mediates the cell-lethal phenotype of double-stranded RNA editing enzyme ADAR1 deficiency in a human cell line.Induction of stress granules by interferon and down-regulation by the cellular RNA adenosine deaminase ADAR1.An RNA editor, adenosine deaminase acting on double-stranded RNA (ADAR1).RNA editing by the host ADAR system affects the molecular evolution of the Zika virus.Identification of widespread ultra-edited human RNAs.Adenosine deaminase acting on RNA 1 limits RIG-I RNA detection and suppresses IFN production responding to viral and endogenous RNAs.Modelling mutational and selection pressures on dinucleotides in eukaryotic phyla--selection against CpG and UpA in cytoplasmically expressed RNA and in RNA viruses Host response to polyomavirus infection is modulated by RNA adenosine deaminase ADAR1 but not by ADAR2 ADAR proteins: double-stranded RNA and Z-DNA binding domains.The emerging role of RNA editing in plasticity.Adenosine deaminase acting on RNA 1 (ADAR1) suppresses the induction of interferon by measles virus.ADAR1 Facilitates HIV-1 Replication in Primary CD4+ T Cells Measles Virus Defective Interfering RNAs Are Generated Frequently and Early in the Absence of C Protein and Can Be Destabilized by Adenosine Deaminase Acting on RNA-1-Like Hypermutations.The RNA-editing enzyme ADAR1 controls innate immune responses to RNA.STAT2-dependent induction of RNA adenosine deaminase ADAR1 by type I interferon differs between mouse and human cells in the requirement for STAT1 Mechanistic insights into editing-site specificity of ADARs.Emerging roles of interferon-stimulated genes in the innate immune response to hepatitis C virus infection Stress granule formation induced by measles virus is protein kinase PKR dependent and impaired by RNA adenosine deaminase ADAR1 Editing of Cellular Self-RNAs by Adenosine Deaminase ADAR1 Suppresses Innate Immune Stress Responses Learning from the messengers: innate sensing of viruses and cytokine regulation of immunity - clues for treatments and vaccines.Investigating the Influence of Ribavirin on Human Respiratory Syncytial Virus RNA Synthesis by Using a High-Resolution Transcriptome Sequencing Approach.

P2860

Q26741496-6A90E8D9-506E-4B9E-85ED-086D89BAE8C3 Q26747114-1898AD35-0D75-445D-84DB-C120668F990E Q26773989-6EB16390-6847-404E-AA78-4B9245CFE8DC Q26776422-0213922C-A535-4618-81FA-445F31785C25 Q26776423-4C195798-46A2-46A6-BBA7-C70B61EBD9F2 Q26782034-45207C26-A225-4099-A11C-9712B8EAB490 Q26853110-D50FAB32-EC53-4D74-929C-A4479FC61BE9 Q26864048-31894E7E-4E4C-4205-B50E-74CB98B78FF6 Q27001020-303610C3-8BC0-4412-ADB6-99D059B3C441 Q28078569-3E0FB9B8-54A6-4F57-ADB3-D7FBD0E23FD8 Q28087310-2AE2AD49-F368-405E-8A5A-F60EA30989E7 Q28115759-F0EFE08C-D2F0-46F6-B08A-DB49B3BEE274 Q28235509-C91AD0A6-8881-4FF8-9592-11422C49A2E7 Q28256088-164CCF10-EB7D-47D1-9270-F1039734CF7D Q28603994-48DA9B33-E91E-4F07-9A34-AE89910A95ED Q28606601-5E101440-698D-44EA-ADA1-5AFDA6328DA0 Q28652541-BFCF5A11-2054-4D64-9E49-DD4E95FA3F2D Q30224621-D6FCE1EE-7FE9-4110-95B0-3AC954626DCE Q30991708-ABB098CD-8BA4-435C-B9B0-BAA08B844C96 Q33602942-2FF298DB-EF8A-48F9-986A-769611D09D03 Q33699353-23EF9CEF-F70C-4241-8B39-0A3BA2FE0F9E Q33714407-AA55B200-C058-44B0-96D1-B91C040ABDD6 Q33817213-1F485AB4-BA0D-4873-8A22-8CC7E05A6885 Q34058176-FD723FEE-28AE-46E3-824A-75E95269CEA5 Q34218597-1E4F92DB-E12F-4B1A-83CC-81CCD7584568 Q34982966-5D2FDDC2-4833-4ACE-923D-4078F5A3E5FF Q35140473-18AE5076-EC6C-45BD-8956-356383A6A3F8 Q35578834-3B91CC77-930D-4736-AC82-50CCC322840F Q35803384-87E32AC3-95A7-4D4E-AFEB-56B87BA79FD3 Q35826798-57ECD921-9283-4124-A797-CBFA558D744C Q35858559-C1E10FF7-2D19-405C-9650-1734BE414A96 Q35861183-010451B7-0369-4494-97E2-93D7BAA3E383 Q35973393-06F4583E-1FD5-4189-9CE8-F266A4DEA42E Q36202710-812EDE97-E340-42DC-B902-0F3490A59EE4 Q36438418-574DF77A-EA23-48D5-9AB1-F2D8467A87D2 Q36460968-40ADD872-1225-429F-944A-F74E1397F0D2 Q36559490-2C811A12-B20E-4196-BD7E-4774BD074227 Q36744764-F442A1E8-D4E4-42BC-BD59-DC903114AB4E Q36807121-D8A2213E-C639-48AB-BA1C-5337DBB7E495 Q36878963-3B027654-5CEA-4217-89F6-D15F4EBE0A70

P2860

Adenosine deaminases acting on RNA (ADARs) are both antiviral and proviral

http://www.wikidata.org/entity/Q28302608

description

2011 nî lūn-bûn

@nan

2011 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի մարտին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Adenosine deaminases acting on RNA (ADARs) are both antiviral and proviral

@ast

Adenosine deaminases acting on RNA (ADARs) are both antiviral and proviral

@en

Adenosine deaminases acting on RNA (ADARs) are both antiviral and proviral

@nl

type

label

Adenosine deaminases acting on RNA (ADARs) are both antiviral and proviral

@ast

Adenosine deaminases acting on RNA (ADARs) are both antiviral and proviral

@en

Adenosine deaminases acting on RNA (ADARs) are both antiviral and proviral

@nl

prefLabel

Adenosine deaminases acting on RNA (ADARs) are both antiviral and proviral

@ast

Adenosine deaminases acting on RNA (ADARs) are both antiviral and proviral

@en

Adenosine deaminases acting on RNA (ADARs) are both antiviral and proviral

@nl

P1433

Q28302608-0602DCF2-14DC-4C6C-8CDD-2366FAEA931A

P1476

Q28302608-1B947ECC-3027-40BE-A991-8C82835E15D1

P2093

Q28302608-2898F847-461B-4327-94C1-427330FC22A9

P2860

Q28302608-04A50264-7D3E-4527-9174-5D616B752F31

Q28302608-07FFC2EA-C8EC-463F-BA60-F93A662EDE17

Q28302608-095F61A0-2F5E-47EF-951C-59AA3F68DF52

Q28302608-09688483-AB4D-4F37-9514-7712CABA6FD2

Q28302608-0AEF65D3-5327-43E3-AD53-7F476EEFF87B

Q28302608-0C0FABBB-0B86-478B-B507-2652C73E17C3

Q28302608-0D19CD15-7020-4EB7-B156-194959FE8BBA

Q28302608-0D355A78-8C44-4AA4-888B-1D8AA6A778CA

Q28302608-0EBB5AB4-70CB-40C2-8B65-BAE03EE6009A

Q28302608-1051D2FB-A7FA-478B-9F2F-68556D9A03C7

P304

Q28302608-3520873F-5E5E-4C93-ABA5-952E73E7EEF4

P31

Q28302608-06932392-814D-4DD8-AAFF-F4898C157DBD

P3181

Q28302608-69C0FFDA-7A13-4E94-81DC-1D92C831DE4D

P356

Q28302608-60D43A5B-78ED-443A-BCC1-51F568C59C33

P407

Q28302608-CD351A22-F83B-4172-8183-C4DD7FF3C60D

P433

Q28302608-305354F9-FC52-47CD-8705-5985CC4484FB

P478

Q28302608-14ED010B-95C6-4D1F-A957-4D19464A30D1

P577

Q28302608-C592B42C-454E-4624-8528-6386EB854F1E

P5875

Q28302608-2C351A5A-2906-42BA-8C36-B76009ED6B52

P698

Q28302608-8770AC2B-A7BA-4B31-9595-93EFB9079948

P932

Q28302608-E551FCE3-3EF1-47FB-83DC-AD71C8CC4273

P3181

P356

J.VIROL.2010.12.004

P1433

P1476

Adenosine deaminases acting on RNA (ADARs) are both antiviral and proviral

@en

P2093

Charles E Samuel

http://www.w3.org/2001/XMLSchema#string

P2860

A third member of the RNA-specific adenosine deaminase gene family, ADAR3, contains both single- and double-stranded RNA binding domains

New antiviral pathway that mediates hepatitis C virus replicon interferon sensitivity through ADAR1

Identification of host proteins required for HIV infection through a functional genomic screen

Expression and regulation by interferon of a double-stranded-RNA-specific adenosine deaminase from human cells: evidence for two forms of the deaminase

Purification of human double-stranded RNA-specific editase 1 (hRED1) involved in editing of brain glutamate receptor B pre-mRNA

RNA-regulated interaction of transportin-1 and exportin-5 with the double-stranded RNA-binding domain regulates nucleocytoplasmic shuttling of ADAR1

The editing enzyme ADAR1 and the mRNA surveillance protein hUpf1 interact in the cell nucleus

Editing of glutamate receptor B subunit ion channel RNAs by four alternatively spliced DRADA2 double-stranded RNA adenosine deaminases

Functionally distinct double-stranded RNA-binding domains associated with alternative splice site variants of the interferon-inducible double-stranded RNA-specific adenosine deaminase

Editing of HIV-1 RNA by the double-stranded RNA deaminase ADAR1 stimulates viral infection

P304

180-93

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

3994305

http://www.w3.org/2001/XMLSchema#string

P356

10.1016/J.VIROL.2010.12.004

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

411

http://www.w3.org/2001/XMLSchema#string

P577

2011-03-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

49734105

http://www.w3.org/2001/XMLSchema#string

P698

21211811

http://www.w3.org/2001/XMLSchema#string

P932

3057271

http://www.w3.org/2001/XMLSchema#string